Building Cross-Industry Models for Patient-Centric Evidence with Lessons from the H2O Project

• Scaling Beyond EHDS – How collaborative frameworks like H2O complement the EHDS by enabling cross-border, multi-stakeholder data access and addressing regulatory expectations
• Practical lessons from H2O on capturing patient outcomes in a way that satisfies regulators, HTA bodies, and payers while maintaining patient trust
• Cross-industry data sharing with governance models that make it possible for pharma, providers, regulators, and patients to collaborate on shared evidence platforms

Speakers:

Melpomeni Styliadou

Vice President Global Program Leader, Health Data Partnerships

Takeda Pharmaceuticals